Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39584002P | 2002-07-15 | 2002-07-15 | |
US43272102P | 2002-12-12 | 2002-12-12 | |
PCT/US2003/020706WO2004006889A1 (en) | 2002-07-15 | 2003-06-30 | Bioerodible film for ophthalmic drug delivery |
Publication Number | Publication Date |
---|---|
DK1521572T3true DK1521572T3 (da) | 2009-05-04 |
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03764333TDK1521572T3 (da) | 2002-07-15 | 2003-06-30 | Biologisk nedbrydelig film til indförsel af öjenlægemiddel |
Country | Link |
---|---|
US (1) | US8084054B2 (da) |
EP (1) | EP1521572B1 (da) |
JP (1) | JP4454019B2 (da) |
KR (1) | KR101003514B1 (da) |
CN (1) | CN100500221C (da) |
AT (1) | ATE424187T1 (da) |
AU (1) | AU2003247671B2 (da) |
CA (1) | CA2491312C (da) |
CY (1) | CY1109606T1 (da) |
DE (1) | DE60326455D1 (da) |
DK (1) | DK1521572T3 (da) |
ES (1) | ES2321083T3 (da) |
MX (1) | MXPA05000631A (da) |
PL (1) | PL206379B1 (da) |
PT (1) | PT1521572E (da) |
SI (1) | SI1521572T1 (da) |
WO (1) | WO2004006889A1 (da) |
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060257450A1 (en)* | 2005-03-21 | 2006-11-16 | Sreenivasu Mudumba | Drug delivery systems for treatment of diseases or conditions |
JP5591226B2 (ja) | 2008-05-12 | 2014-09-17 | ユニバーシティ・オブ・ユタ・リサーチ・ファウンデイション | 眼内薬物送達装置および関連する方法 |
US9095404B2 (en) | 2008-05-12 | 2015-08-04 | University Of Utah Research Foundation | Intraocular drug delivery device and associated methods |
US9877973B2 (en) | 2008-05-12 | 2018-01-30 | University Of Utah Research Foundation | Intraocular drug delivery device and associated methods |
US10064819B2 (en) | 2008-05-12 | 2018-09-04 | University Of Utah Research Foundation | Intraocular drug delivery device and associated methods |
SG173167A1 (en) | 2009-01-29 | 2011-08-29 | Forsight Labs Llc | Posterior segment drug delivery |
US8623395B2 (en) | 2010-01-29 | 2014-01-07 | Forsight Vision4, Inc. | Implantable therapeutic device |
WO2013022801A1 (en) | 2011-08-05 | 2013-02-14 | Forsight Vision4, Inc. | Small molecule delivery with implantable therapeutic device |
CN103189097B (zh)* | 2010-07-29 | 2016-01-06 | 参天制药株式会社 | 带药剂的支承体及其制造方法 |
JP6111194B2 (ja) | 2010-08-05 | 2017-04-05 | フォーサイト・ビジョン フォー・インコーポレーテッド | 組み合わせ薬物送達方法および装置 |
WO2012019176A2 (en) | 2010-08-05 | 2012-02-09 | Forsight Vision4 Inc. | Implantable therapeutic device |
LT2600930T (lt) | 2010-08-05 | 2021-04-12 | Forsight Vision4, Inc. | Injekcinis aparatas, skirtas vaisto tiekimui |
WO2012068549A2 (en) | 2010-11-19 | 2012-05-24 | Forsight Vision4, Inc. | Therapeutic agent formulations for implanted devices |
WO2012153870A1 (ja)* | 2011-05-11 | 2012-11-15 | 帝人株式会社 | 緑内障治療材 |
US20120302954A1 (en)* | 2011-05-25 | 2012-11-29 | Zhao Jonathon Z | Expandable devices coated with a paclitaxel composition |
WO2013003620A2 (en) | 2011-06-28 | 2013-01-03 | Forsight Vision4, Inc. | Diagnostic methods and apparatus |
EP3903733A1 (en) | 2011-09-16 | 2021-11-03 | ForSight Vision4, Inc. | Fluid exchange apparatus |
US10010448B2 (en) | 2012-02-03 | 2018-07-03 | Forsight Vision4, Inc. | Insertion and removal methods and apparatus for therapeutic devices |
CA2878680C (en) | 2012-07-23 | 2019-09-17 | Crayola, Llc | Dissolvable films and methods of using the same |
US9968603B2 (en) | 2013-03-14 | 2018-05-15 | Forsight Vision4, Inc. | Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant |
AU2014241163B2 (en) | 2013-03-28 | 2018-09-27 | Forsight Vision4, Inc. | Ophthalmic implant for delivering therapeutic substances |
JP6581194B2 (ja) | 2014-07-15 | 2019-09-25 | フォーサイト・ビジョン フォー・インコーポレーテッドForsight Vision4, Inc. | 眼用インプラント送達装置および方法 |
AU2015301054B2 (en) | 2014-08-08 | 2020-05-14 | Forsight Vision4, Inc. | Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof |
KR20170106298A (ko) | 2014-11-10 | 2017-09-20 | 포사이트 비젼4, 인크. | 확장 가능한 약물 전달 장치 및 이용 방법 |
MX2018006234A (es) | 2015-11-20 | 2018-08-14 | Forsight Vision4 Inc | Estructuras porosas para dispositivos de suministro de medicamentos de liberacion prolongada. |
WO2017176886A1 (en) | 2016-04-05 | 2017-10-12 | Forsight Vision4, Inc. | Implantable ocular drug delivery devices |
WO2019103906A1 (en) | 2017-11-21 | 2019-05-31 | Forsight Vision4, Inc. | Fluid exchange apparatus for expandable port delivery system and methods of use |
USD1033637S1 (en) | 2022-01-24 | 2024-07-02 | Forsight Vision4, Inc. | Fluid exchange device |
WO2024059952A1 (en)* | 2022-09-23 | 2024-03-28 | Madd Ophthalmics Ltd. | Mucoadhesive drug delivery systems and methods of use |
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6042766B2 (ja)* | 1978-12-09 | 1985-09-25 | 日本化薬株式会社 | 基剤 |
GB8524421D0 (en)* | 1985-10-03 | 1985-11-06 | Boots Co Plc | Therapeutic agents |
US4880636A (en)* | 1988-05-13 | 1989-11-14 | Franz Robert M | Film coated tablet of ranitidine HCl |
US4865846A (en)* | 1988-06-03 | 1989-09-12 | Kaufman Herbert E | Drug delivery system |
US6117425A (en)* | 1990-11-27 | 2000-09-12 | The American National Red Cross | Supplemented and unsupplemented tissue sealants, method of their production and use |
HU219242B (en)* | 1991-05-13 | 2001-03-28 | Boots Co Plc | S(+)-ibuprofen sodium salt dihydrate, pharmaceutical composition comprising this compound and process for production of them |
GB9213077D0 (en)* | 1992-06-19 | 1992-08-05 | Erba Carlo Spa | Polymerbound taxol derivatives |
US5614549A (en)* | 1992-08-21 | 1997-03-25 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
US5362478A (en)* | 1993-03-26 | 1994-11-08 | Vivorx Pharmaceuticals, Inc. | Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell |
US6096331A (en)* | 1993-02-22 | 2000-08-01 | Vivorx Pharmaceuticals, Inc. | Methods and compositions useful for administration of chemotherapeutic agents |
US6537579B1 (en) | 1993-02-22 | 2003-03-25 | American Bioscience, Inc. | Compositions and methods for administration of pharmacologically active compounds |
EP0693924B2 (en)* | 1993-02-22 | 2008-04-09 | Abraxis BioScience, Inc. | Methods for (in vivo) delivery of biologics and compositions useful therefor |
US5916596A (en)* | 1993-02-22 | 1999-06-29 | Vivorx Pharmaceuticals, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
US5439686A (en)* | 1993-02-22 | 1995-08-08 | Vivorx Pharmaceuticals, Inc. | Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor |
US5665382A (en)* | 1993-02-22 | 1997-09-09 | Vivorx Pharmaceuticals, Inc. | Methods for the preparation of pharmaceutically active agents for in vivo delivery |
US5716981A (en)* | 1993-07-19 | 1998-02-10 | Angiogenesis Technologies, Inc. | Anti-angiogenic compositions and methods of use |
TW406020B (en)* | 1993-09-29 | 2000-09-21 | Bristol Myers Squibb Co | Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent |
US5433951A (en)* | 1993-10-13 | 1995-07-18 | Bristol-Myers Squibb Company | Sustained release formulation containing captopril and method |
US5484608A (en)* | 1994-03-28 | 1996-01-16 | Pharmavene, Inc. | Sustained-release drug delivery system |
US5626862A (en)* | 1994-08-02 | 1997-05-06 | Massachusetts Institute Of Technology | Controlled local delivery of chemotherapeutic agents for treating solid tumors |
US6063116A (en)* | 1994-10-26 | 2000-05-16 | Medarex, Inc. | Modulation of cell proliferation and wound healing |
US5783178A (en)* | 1994-11-18 | 1998-07-21 | Supratek Pharma. Inc. | Polymer linked biological agents |
US6369116B1 (en)* | 1995-06-02 | 2002-04-09 | Oculex Pharmaceuticals, Inc. | Composition and method for treating glaucoma |
RU2086218C1 (ru) | 1995-07-26 | 1997-08-10 | Санкт-Петербургская медицинская академия последипломного образования | Способ лечения глаукомы |
US5736152A (en)* | 1995-10-27 | 1998-04-07 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
EP1616563A3 (en) | 1996-05-24 | 2006-01-25 | Angiotech Pharmaceuticals, Inc. | Perivascular administration of anti-angiogenic factors for treating or preventing vascular diseases |
US5888493A (en)* | 1996-12-05 | 1999-03-30 | Sawaya; Assad S. | Ophthalmic aqueous gel formulation and related methods |
KR100923172B1 (ko) | 1997-06-27 | 2009-10-22 | 아브락시스 바이오사이언스, 엘엘씨 | 신규 약물 제제 |
US6004573A (en)* | 1997-10-03 | 1999-12-21 | Macromed, Inc. | Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties |
US20020164374A1 (en) | 1997-10-29 | 2002-11-07 | John Jackson | Polymeric systems for drug delivery and uses thereof |
US6146659A (en)* | 1998-07-01 | 2000-11-14 | Neopharm, Inc. | Method of administering liposomal encapsulated taxane |
US6017948A (en)* | 1998-10-30 | 2000-01-25 | Supergen, Inc. | Water-miscible pharmaceutical compositions |
CA2367387C (en)* | 1999-03-16 | 2009-06-23 | Herwig Buchholz | Composition comprising isoquercetin and ascorbic acid in a sustained release form |
WO2000064437A1 (en) | 1999-04-22 | 2000-11-02 | American Biosciences, Inc. | Long term administration of pharmacologically active agents |
US6306120B1 (en)* | 1999-06-07 | 2001-10-23 | Ben Gee Tan | Applicator and method for delivery of mitomycin to eye tissues during glaucoma filtering surgery |
US6375963B1 (en)* | 1999-06-16 | 2002-04-23 | Michael A. Repka | Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof |
EP1387676A2 (en)* | 2001-05-01 | 2004-02-11 | Angiotech Pharmaceuticals, Inc. | Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions |
US20040058313A1 (en)* | 2002-04-24 | 2004-03-25 | Abreu Marcio Marc | Compositions, targets, methods and devices for the therapy of ocular and periocular disorders |
Publication number | Publication date |
---|---|
WO2004006889A1 (en) | 2004-01-22 |
AU2003247671A1 (en) | 2004-02-02 |
EP1521572A1 (en) | 2005-04-13 |
EP1521572B1 (en) | 2009-03-04 |
CA2491312A1 (en) | 2004-01-22 |
CY1109606T1 (el) | 2014-08-13 |
JP4454019B2 (ja) | 2010-04-21 |
CN1668278A (zh) | 2005-09-14 |
KR20050025961A (ko) | 2005-03-14 |
ATE424187T1 (de) | 2009-03-15 |
US20040126408A1 (en) | 2004-07-01 |
SI1521572T1 (sl) | 2009-06-30 |
MXPA05000631A (es) | 2005-03-31 |
CA2491312C (en) | 2011-05-31 |
PL374764A1 (en) | 2005-10-31 |
DE60326455D1 (de) | 2009-04-16 |
PL206379B1 (pl) | 2010-08-31 |
ES2321083T3 (es) | 2009-06-02 |
KR101003514B1 (ko) | 2010-12-30 |
US8084054B2 (en) | 2011-12-27 |
PT1521572E (pt) | 2009-04-21 |
AU2003247671B2 (en) | 2008-02-14 |
CN100500221C (zh) | 2009-06-17 |
JP2005533106A (ja) | 2005-11-04 |
Publication | Publication Date | Title |
---|---|---|
DK1521572T3 (da) | Biologisk nedbrydelig film til indförsel af öjenlægemiddel | |
DE60135486D1 (de) | Zusammensetzungen zur verzögerten abgabe von hydrophoben arzneimitteln und verfahren zu ihrer herstellung | |
PT1061900E (pt) | Composicoes e metodos para libertacao de uma droga | |
MX344532B (es) | Composiciones de farmaco de liberacion sostenida convenientemente implantables. | |
CY1105877T1 (el) | Οφθαλμικες συνθεσεις πepιεχουσες συνepγιστικο συνδυασμο τριων πολυμepων | |
CY1115707T1 (el) | Στερεα σταθεροποιημενα θεραπευτικα συστηματα ταχειας και/ή τροποποιημενης απελευθερωσης για τη χορηγηση απο του στοματος υγρων δραστικων ουσιων, εκδοχων ή τροφιμων | |
WO2004009445A3 (en) | Packaging and dispensing of rapid dissolve dosage form | |
MA34832B1 (fr) | Compositions biodegradables d'administration de medicaments | |
MX2009008170A (es) | Nuevos biomateriales para la distribucion de farmaco ocular y metodo para hacerlos y utilizarlos. | |
AU2003237288A1 (en) | Biodegradable block copolymeric compositions for drug delivery | |
DE60330144D1 (de) | Beschichtung von stents mit verzögerter wirkstofffreisetzung | |
WO2008011125A3 (en) | Devices, systems and methods for ophthalmic drug delivery | |
HUP0203451A2 (hu) | Új, tuberkolózis elleni gyógyszerkészítmények és eljárás előállításukra | |
CY1108700T1 (el) | Συνθεσεις απελευθερωσης φαρμακου εστερα αλφα-υδροξυ οξεος και μεθοδοι χρησης | |
EA200501819A1 (ru) | Способы и фармацевтические композиции для достоверного достижения приемлемых уровней тестостерона в сыворотке | |
BR0313428A (pt) | Composições farmacêuticas de drogas semi-ordenados e polìmeros | |
HRP20080178T3 (en) | Pharmaceutical composition in the form of a hydrogel for transdermal administration of active substances | |
DK1957037T3 (da) | Farmaceutisk præparat til nasal anvendelse af fentanyl | |
WO2008027793A3 (en) | Ophthalmic pharmaceutical compositions and uses thereof | |
WO2002034240A3 (en) | Delayed and sustained release formulations and method of use thereof | |
DE602006012962D1 (de) | Pharmazeutische Zubereitungen von Ciprofloxacin | |
WO2006060325A3 (en) | Coated drug delivery formulations | |
AU2003256882A1 (en) | Methods of drug delivery using sulphated chitinous polymers | |
TR200601092T1 (tr) | İrbesartan etkin maddesi içeren yeni oral farmasötik formülasyonlar. | |
EA200601015A1 (ru) | Пероральные композиции дезоксипеганина и их применение |